Trials / Completed
CompletedNCT00288951
Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 690 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and IOP-lowering ability of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost 0.004% with and without BAK |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2005-06-01
- Completion
- 2005-06-01
- First posted
- 2006-02-09
- Last updated
- 2012-08-17
Source: ClinicalTrials.gov record NCT00288951. Inclusion in this directory is not an endorsement.